Outcomes of FOLFIRINOX versus Gemcitabine plus nab-Paclitaxel in Patients with Early Recurrent Pancreatic Cancer after Adjuvant S-1 Treatment: A propensity Score-matched Analysis
30 Aug 2025, 2 p.m.
Publication date: Available online 30 August 2025Source: PancreatologyAuthor(s): Naohiro Okano, ...